Physician profile
Daniel Wayne Pace
NPI 1447271721
$3,914.24
in general payments reported to CMS, 2019-2025
12 companies · $1,065 in 2025
The $1,065 reported for 2025 was more than what 86% of Corneal and Contact Management providers received nationally (typical 2025 total: $227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $350 · 2020: $230 · 2021: $587 · 2022: $536 · 2023: $568 · 2024: $578 · 2025: $1,065.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,149 · Entertainment: $62.21.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,149.02 |
| Entertainment | $62.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $1,544.47 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $839.98 | 2019-2025 | Precision7, Precision 1, Dailies Total1 |
| Bausch & Lomb Americas INC. | $603.42 | 2022-2025 | Infuse, Biotrue One Day, Btod |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $340.46 | 2019-2021 | |
| Coopervision INC. | $166.05 | 2019-2025 | Myday Contact Lens, Misight Contact Lens |
| Tarsus Pharmaceuticals, INC. | $121.37 | 2025 | Xdemvy |
| Biotissue Holdings INC. | $111.11 | 2023 | |
| Optos, INC. | $85.21 | 2022-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Abb Con-Cise Optical Group LLC | $40.65 | 2019 | |
| Allergan, INC. | $24.78 | 2022 | |
| Sun Pharmaceutical Industries INC. | $22.80 | 2025 | |
| Dompe US, INC. | $13.94 | 2025 | Oxervate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Pace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.